您好,欢迎访问三七文档
当前位置:首页 > 商业/管理/HR > 经营企划 > 超滤法纯化C群脑膜炎球菌荚膜多糖降解物的工艺优化周晖国
20188318ChinJBiologicalsAugust2018Vol.31No.81。2。、3730046C。300000C300kDa、1~6、0.15mol/LNaCl、0.5mol/LNaCl、50mmol/LPBSH2O、0.25、0.51mg/mL。C。C0.15mol/LNaCl51.0mg/mL。C80%。C。CR378.1+5R392-33A1004-5503201808-0896-06OptimizationofpurificationprocedureforcapsularpolysaccharidehydrolyzateofNeisseriameningitidisgroupCbyultrafiltrationZHOUHui-guoZHANGHai-hongYUANFeiLUOShu-quanLIA-niYINGLian-fangLanzhouInstituteofBiologicalProductsCo.Ltd.Lanzhou730046GansuProvinceChinaCorrespondingauthorYINGLian-fangE-mailyinglf1965@sina.comAbstractObjectiveTooptimizethepurificationprocessforcapsularpolysaccharidehydrolyzateofNeisseriameningitidisgroupCbyultrafiltration.MethodsThecapsularpolysaccharidehydrolyzateofN.meningitidisgroupCwaspurifiedbyultrafiltrationusingtheultrafiltrationmembranewithrelativemolecularmasscutoffof300000.Theultrafiltrationmembranematerial300kDapolyethersulfonemembraneandregeneratedcellulosecompositemembranetimesofdialysis1~6ultrafiltrationbuffer0.15mol/Lsodiumchloride0.5mol/Lsodiumchloride50mmol/LPBSandwaterinitialliquidconcentrationofpolysaccharide0.250.5and1mg/mLandultrafiltrationmethodconcentratedultrafiltrationandconstantvolumeultrafiltrationwereoptimizedusingmembranefluxandpolysacchariderecoveryrateasevaluationindexes.Thehydrolyzatepurifiedundertheoptimalconditionwastested.ResultsTheoptimalultrafiltrationmembraneultrafiltrationbuffertimeofdialysisinitialliquidconcentrationofpolysaccharideandultrafiltrationmethodforhydrolyzateofcapsularpolysaccharidesofN.meningitidisgroupCwereregeneratedcellulosecompositemembrane0.15mol/Lsodiumchloride5times1.0mg/mLandconcentratedultrafiltrationrespectively.Underthisconditionthepolysaccharidecomponentswithhighrelativemolecularmasseswereeffectivelyremovedwhilethepolysacchariderecoveryratewasmorethan80%andthepolysaccharidehydrolyzateendotoxincontentdecreasedtoacertainextent.ConclusionThepurificationprocedureforcapsularpolysaccharidehydrolyzateofN.meningitidisgroupCwassuccessfullyoptimizedwhichsignificantlyimprovedtheworkingefficiency.KeywordsUltrafiltrationNeisseriameningitidisgroupCCapsularpolysaccharideHydrolyzateProcedureopti-mization··E-mailyinglf1965@sina.com896··DOI:10.13200/j.cnki.cjb.00226620188318ChinJBiologicalsAugust2018Vol.31No.8。。g/mol。1~2、34-5。。、、、。C、、、。11.1CHP-201604001。1.2NaAc、H2O2、NaCl、Na2HPO4、NaH2PO4LabscaleMilliporeAKTApurifier100GE。1.3RYALL6。50mmol/LpH6.0C10mg/mL0.5%H2O237℃2h10℃。1.450mgC20Psi20℃LabscaleJR。JL/m2·h=V/A×TVLAm2Th。R%=C1×V1/C0×V0C1V1mLmg/mLC0V0mLmg/mL。1.51.5.1300kDaC0.15mol/LNaCl200mL0.25mg/mL20mL0.15mol/LNaCl200mL4。、、。1.5.2300kDaC0.15mol/LNaCl200mL0.25mg/mL1~6。1.5.30.15mol/LNaCl、0.5mol/LNaCl、50mmol/LPBS0.15mol/LNaClpH7.2H2O200mL0.25mg/mL300kDa5。1.5.40.15mol/LNaCl0.25、0.51mg/mL300kDa5。1.5.5300kDaC0.15mol/LNaCl200mL1.0mg/mL5800mL0.15mol/LNaCl。1.6400mgC10kDa。、、1H1HNMR。1.6.1《》2015897··20188318ChinJBiologicalsAugust2018Vol.31No.87。1.6.2《》2015SepharoseCL-4B7。1.6.3《》20157。1.6.4NMR8。22.12.1.1300kDa300kDa80%。11。。1Tab1.EffectofmembranematerialonultrafiltrationpurificationL/m2·h%32389.2928581.982.1.2652。2Tab2.EffectofultrafiltrationtimesonmembranefluxandtherecoveryrateofpolysaccharidesL/m2·h%129046.63229066.16329675.10430480.12530883.17632083.952.1.30.15mol/LNaCl、0.5mol/LNaCl50mmol/LPBS0.15mol/LNaClpH7.284%H2O351L/m2·h23%。3。0.15mol/LNaCl。ABC。1CFig1.Effectofmembranematerialonultrafiltrationsepa-rationofcapsularpolysaccharidehydrolyzateofN.meningitidisgroupC3Tab3.EffectofvariousultrafiltrationbuffersonmembranefluxandrecoveryrateofpolysaccharidesL/m2·h%0.15mol/LNaCl29884.250.5mol/LNaCl29483.9850mmol/LPBS28484.28H2O35123.25-10.00.010.020.030.01.50.01.00.5150501000CmLmAUmAU-10.00.010.020.030.01.50.01.00.5150501000BmLmAUmAU1.50.01.00.5-0.5-1.0150501000-10.00.010.020.030.040.0AmLmAUmAU898··20188318ChinJBiologicalsAugust2018Vol.31No.82.1.40.25mg/mL0.51mg/mL3。4。、1mg/mL。4Tab4.Effectofinitialliquidconcentrationofpolysaccharideonmembranefluxandrecoveryrateofpolysaccharidesmg/mLL/m2·h%0.2529883.170.520888.66118481.582.1.567.8%262L/m2·h5。。5Tab5.EffectofultrafiltrationmethodonmembranefluxandrecoveryrateL/m2·h%30585.326267.82.21mg/mL10000~30000094.65%88.16%>30000080.24%2.230.095EU/μg>30000023.91EU/μg10000~30000080.79%。6。“”V0>300000V0280nm2。1.30.9ppm3。6Tab6.Controltestsonpolysaccharidehydrolyzatebeforeandafterultrafiltrationpurificationmg%EU/μg%40088.162.23/>3000005480.2423.9112.2910000~30194.650.09580.7930000093.08AB300000C300kDa。2CFig2.Molecularsizedistributionofpolysaccharidehydro-lyzatebeforeandafterultrafiltrationpurification-20.00.080.020.060.040.0100.00.05.04.03.02.01.0150501000mAUmL1.50.01.00.5-0.5-1.0150501000-10.00.010.020.030.040.0mAUmAUmLmAU-20.00.080.020.060.040.0150501000mAUmL1.50.01.00.5-0.5-1.02.02.5mAUABC899··20188318ChinJBiologicalsAugust2018Vol.31No.85.51.52.53.54.50.05.04.03.02.01.00.5ppmA125.51.52.53.54.50.05.04.03.02.01.00.5ppmB12AB300kDa。11.3ppm20.9ppm。3C1HNMRFig3.NMRspectraofpolysaccharidehydrolyzatebeforeandafterultrafiltrationpurification3。、、、、。C。3~5300kDa。HADIDI9300kDaUltracel8.4±0.1nm300kDaBiomax9.3±0.1nm1000kDaUltracel9.4±0.1nm。。。FOSCHIATTI10A。
本文标题:超滤法纯化C群脑膜炎球菌荚膜多糖降解物的工艺优化周晖国
链接地址:https://www.777doc.com/doc-6547052 .html